Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: Results of a naturalistic clinical trial Academic Article uri icon

Overview

MeSH Major

  • Antimanic Agents
  • Bipolar Disorder
  • Health Care Costs
  • Lithium
  • Valproic Acid

abstract

  • Divalproex maintenance treatment for bipolar disorder resulted in comparable medical costs, clinical and QOL outcomes compared with lithium. Patients remaining on mood stabilizer therapy had substantially lower total medical costs and better health outcomes compared with those who discontinued therapy.

publication date

  • June 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jad.2005.01.002

PubMed ID

  • 15935238

Additional Document Info

start page

  • 183

end page

  • 93

volume

  • 86

number

  • 2-3